Oxetacaine PCD Pharma Franchise Company
Cafoli Lifecare is a reliable Oxetacaine PCD pharma franchise company in India, offering 9 Oxetacaine formulations across suspension, syrup and tablets within its gastro portfolio. All products are manufactured at WHO-GMP certified, DCGI-approved facilities and offered to franchise partners with exclusive district-wise monopoly rights.
What is Oxetacaine?
Oxetacaine (also spelled oxethazaine) is a topical local anaesthetic used in the gastrointestinal tract. Applied to the mucosa of the oesophagus and stomach, it blocks sodium channels in local sensory nerve endings, interrupting the transmission of pain signals from inflamed or ulcerated tissue and producing rapid symptomatic relief. It is almost always formulated in combination with antacids such as aluminium hydroxide and magnesium hydroxide, so that the anaesthetic numbs the irritated surface while the antacid neutralises the gastric acid responsible for the irritation. Compound data is available on PubChem.
Available Oxetacaine Formulations
The Cafoli Lifecare Oxetacaine range comprises 9 formulations in the following dosage forms:
Brand names, compositions, pack sizes and net rates are shared with registered franchise enquiries. Contact our team for the current Oxetacaine price list.
Therapeutic Applications of Oxetacaine
Prescribed under medical supervision for symptomatic relief in:
- Reflux oesophagitis and gastro-oesophageal reflux disease
- Hyperacidity, heartburn and acid dyspepsia
- Gastric and duodenal ulcer, as adjunctive symptomatic therapy
- Painful oesophageal and gastric mucosal irritation
- Gastritis associated with pain and burning
Prescriber specialties: gastroenterologists, consulting physicians, general surgeons and ENT specialists. Oxetacaine combinations provide symptomatic relief and are used alongside, not instead of, definitive acid-suppression therapy where indicated.
Why Oxetacaine is a High-Potential Molecule for Distributors
The gastro-antacid category is enormous in India and fiercely competitive — which is exactly why Oxetacaine matters. Plain antacid suspensions are commodities that compete on price and are freely substituted at the counter; an Oxetacaine combination is not, because it does something the patient can physically feel within minutes. That local anaesthetic effect creates genuine brand recall: patients come back to the pharmacy and ask for the product by name rather than accepting whatever the chemist hands over. For a franchise partner, that pull-through is worth more than any margin advantage, because it converts a one-off prescription into repeat retail demand that does not require re-detailing the doctor. Acid-peptic disease is also chronic and relapsing, and the availability of suspension, syrup and tablet forms lets a single allotment serve retail counters, clinics and hospital wards from the same line.
Why Choose Cafoli Lifecare
- Monopoly rights — exclusive district-wise marketing rights for the Oxetacaine range
- WHO-GMP certified manufacturing and DCGI-approved products
- Promotional inputs — visual aids, MR bags, prescription pads, samples and reminder cards
- 1000+ franchise partners across India with an on-time dispatch record
- Transparent net rates and dedicated franchise support
References
- PubChem — Oxetacaine (oxethazaine) compound record
- PubMed — Oxetacaine-antacid combinations in reflux oesophagitis
- MedlinePlus — GERD (Gastroesophageal Reflux Disease)
Our formulations of Oxetacaine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: